Since reports first began appearing in Israel in early June of some COVID mRNA vaccines causing an increase in heart inflammation or myocarditis, there have been urgent concerns and controversy surrounding the use of new mRNA vaccines. The increasing reports have now forced clinical bodies, including the FDA, to issue a recommendation on the use of the vaccines in the younger population. COVID mRNA vaccines, such as those developed by PfizerBioNTech, Moderna Inc, are not only among the most sought-after vaccines around the world, but they are also highly commented on for their utility and specific ability to target a pathogen after administration is increasing controversy around increased blood clots with the Oxford-Astrazeneca vaccine and Johnson and Johnson’s Jannsen vaccine, Pfizer reports for younger men in the shot put in Israel found an increased risk of myocarditis, prompting the country’s health ministry to conduct investigations referring to myocarditis the condition that occurs when the middle layer of the heart becomes inflamed.
Inflammation is usually caused by a severe infection or virus damage that can weaken the heart’s electrical system, cause heart failure, abnormal (irregular heartbeat), or arrhythmias, and in some Cases even more suddenly Death. Myocarditis, pericarditis, is inflammation of the outer tissues of the heart (pericardium), which if infected can cause problems such as impaired oxygenated blood flow, pain, weakness in muscles and the walls of the heart.
